Procedure for Stability Testing of Drug Products with Multiple Active Ingredients

1) Purpose

The purpose of this SOP is to establish a procedure for conducting stability testing for drug products containing multiple active ingredients in compliance with relevant regulatory guidelines. This ensures that the product maintains its quality, safety, and efficacy throughout its shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of drug products containing multiple active ingredients, including formulation development, quality control, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing multi-active ingredient formulations and selecting appropriate packaging materials.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements and submitting stability data to authorities.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that includes parameters specific to products

with multiple active ingredients, such as assay, impurity profile, and degradation products.

4.1.2 Define storage conditions (e.g., room temperature, accelerated) and testing intervals (e.g., 0, 3, 6, 12 months) based on regulatory guidelines.

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging for stability testing, ensuring that the formulation remains consistent throughout the study.

4.2.2 Store samples under specified conditions as per the protocol, and monitor storage environments continuously.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at all required intervals, including assessments of potency, physical characteristics, and degradation products.

4.3.2 Record all data accurately and ensure compliance with the approved protocol.

4.4 Data Analysis and Reporting

4.4.1 Analyze stability data to detect any trends, deviations, or interactions between active ingredients that could impact product quality.

4.4.2 Prepare a comprehensive stability report for regulatory submission, including all findings and conclusions.

5) Abbreviations, if any

QA: Quality Assurance

6) Documents, if any

6.1 Stability testing protocols
6.2 Data sheets
6.3 Stability reports

7) Reference, if any

FDA Guidance for Industry: Stability Testing of Drug Products with Multiple Active Ingredients

8) SOP Version

Version 1.0